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Abstract
Background:  We present a methodology for high-throughput design of oligonucleotide
fingerprints for microarray-based pathogen diagnostic assays. The oligonucleotide fingerprints, or
DNA microarray probes, are designed for identifying target organisms in environmental or clinical
samples. The design process is implemented in a high-performance computing software pipeline
that incorporates major algorithmic improvements over a previous version to both reduce
computation time and improve specificity assessment.
Results:  The algorithmic improvements result in significant reduction in runtimes, with the
updated pipeline being nearly up to five-times faster than the previous version. The improvements
in specificity assessment, based on multiple specificity criteria, result in robust and consistent
evaluation of cross-hybridization with nontarget sequences. In addition, the multiple criteria
provide finer control on the number of resulting fingerprints, which helps in obtaining a larger
number of fingerprints with high specificity. Simulation tests for Francisella tularensis and Yersinia
pestis, using a well-established hybridization model to estimate cross-hybridization with nontarget
sequences, show that the improved specificity criteria yield a larger number of fingerprints as
compared to using a single specificity criterion.
Conclusion: The faster runtimes, achieved as the result of algorithmic improvements, are critical
for extending the pipeline to process multiple target genomes. The larger numbers of identified
fingerprints, obtained by considering broader specificity criteria, are essential for designing probes
for hard-to-distinguish target sequences.
Background
Recent developments in technology have led to the
sequencing of many eukaryotic and prokaryotic organ-
isms. Availability of these genomic sequences unlocked
opportunities for the development of whole-genome-
based diagnostic assays, such as DNA microarrays and
polymerase chain reaction (PCR) assays, which offer
higher specificity than traditional methods based on a sin-
gle gene or protein [1]. Because of their simplicity and effi-
ciency, these assays are increasingly being used for various
applications in medicine, environmental monitoring, and
biodefense. The popularity of these assays, in turn, trig-
gered the development of different computational tools
for sequence-based signature design [1-4].
Published: 10 April 2008
BMC Bioinformatics 2008, 9:185 doi:10.1186/1471-2105-9-185
Received: 21 November 2007
Accepted: 10 April 2008
This article is available from: http://www.biomedcentral.com/1471-2105/9/185
© 2008 Satya et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Bioinformatics 2008, 9:185 http://www.biomedcentral.com/1471-2105/9/185
Page 2 of 13
(page number not for citation purposes)
Microarray-based pathogen diagnostic assays are gaining
popularity due to their ability to test for hundreds, or even
thousands, of pathogens in a single diagnostic test [5].
Wilson et al. [6] used 50-thousand 20 mer overlapping
oligonucleotides to detect 18 pathogens, Wang et al. [7]
reported using a microarray with 11-thousand 70 mer oli-
gonucleotides that can identify  954 distinct viruses, while
Palacios  et al. [8] designed a panmicrobial microarray
comprising nearly 30-thousand 60 mer probes. Current
technology for custom microarray design enables up to
385000 oligonucleotides per slide, while arrays with 2.1
million probes are available for other high-throughput
applications, such as comparative genome hybridization
[9]. The ability to simultaneously screen against a wide
range of targets is essential for detecting biological threat
agents in environmental samples, where there may be no
prior knowledge about the specific pathogens likely to be
present in the sample.
In terms of the computational problems, the design of
microarray probes for pathogen identification is funda-
mentally different from the design of microarray probes
for gene expression analysis. An oligonucleotide probe
designed for monitoring the expression of a gene should
hybridize only to the mRNA of the corresponding gene,
and should not have any significant cross-hybridization
with other mRNAs from the same organism. Because all
sequences involved are gene transcripts of a single organ-
ism, the combined length of the sequences is typically, at
most, a few megabases. The problem, though computa-
tionally intensive, can be handled by a single processor in
less than an hour [10]. Many efficient computational
tools have been developed for designing microarray
probes for gene expression analysis [10-15].
In contrast, oligonucleotide probes designed for pathogen
diagnostic assays should hybridize only with the intended
target and should not have any significant cross-hybridi-
zation with any nontarget genome. This necessitates the
comparison of each candidate probe against every availa-
ble sequenced nontarget genome. To date, the combined
size of the nucleotide sequences in the National Center for
Biotechnology Information (NCBI) nt database is greater
than 21 gigabases and is bound to grow exponentially as
more and more genomes are sequenced. The amount of
sequence data that need to be analyzed for each target
pathogen is also increasing due to multiple strains of
many pathogens being sequenced. Therefore, the sheer
magnitude of the search space necessitates efficient high-
throughput algorithms that both quickly scan large
genomic databases and reduce the space to a small set of
unique regions in the target genome.
In this paper, we present a software tool for identifying
oligonucleotide fingerprints for microarray-based patho-
gen diagnostic assays. The software, named Tool for Oli-
gonucleotide Fingerprint Identification (TOFI), is an
integrated, scalable, high-performance-computing pipe-
line that combines genome comparison tools, probe
design software, and sequence alignment programs in
order to design highly specific microarray probes for a
given target pathogen (i.e., one complete genomic
sequence). This pipeline (henceforth referred to as TOFI-
beta), is an improvement over an earlier version of the
pipeline (TOFI-alpha), presented by Tembe et al. [4].
TOFI-beta incorporates several optimizations and
enhancements that significantly reduce the overall execu-
tion time of the pipeline, opening up possibilities for
future extension of the system to design fingerprints com-
mon to a group of targets. In addition, TOFI-beta uses
new, multiple criteria for estimating probe specificity,
which, for any given genome, results in a considerable
increase in the number of identified in silico fingerprints
without increase in the (expected) false-positive rate. This
is particularly important in cases where the target
sequence is a close match to other sequences, where the
larger number of in silico fingerprints increases the chance
of identification of true fingerprints.
Existing methods for design of pathogen diagnostic assays
One method to design probes is to select regions of the
pathogen genome that are known to be associated with
specific functions. For example, specific genes of bacterial
genomes, such as the 16S rRNA gene [16], virulence genes
[17], and antibiotic resistance genes [18], have all been
used to design microarray probes for species-level diag-
nostics.
Another method to design probes is to employ the whole
genome of the pathogen. A few software tools/algorithms
have been proposed to guide the design of whole-
genome-based pathogen diagnostic assays [1-4,11-14].
Some of these tools are intended for microarray-based
assays [2,4,11-14], whereas others are intended for PCR-
based assays [1,3]. Most of these tools, however, do not
have the capability of testing for specificity against a large
number of nontarget genomes; they are based on the
assumption that the signatures need only be unique with
respect to the host or a small set of nontarget sequences.
For instance, Kaderali and Schliep [2] developed an algo-
rithm that analyzes a set of input target sequences and
designs a single probe for each target, with the probe
being unique with respect to all other input sequences.
The uniqueness of the probe is determined by construct-
ing a generalized suffix tree for all the input target
sequences. The method presented by Putonti et al. [19]
designs probes that are unique with respect to a host
organism. Both of these approaches are clearly not ade-
quate if the signatures are to identify pathogens from envi-
ronmental samples containing a multitude of nontargetBMC Bioinformatics 2008, 9:185 http://www.biomedcentral.com/1471-2105/9/185
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organisms. Because, in general, there is no prior knowl-
edge of the contaminants in a sample, the signatures have
to be unique with respect to all known nontarget
sequences.
The KPATH pipeline for PCR assays [1] is the seminal soft-
ware that introduced the concept of in silico comparison
against all known nontarget sequences. Insignia [3] is
another tool for designing PCR assays. Unlike the current
version of TOFI, which designs fingerprints for a single
genome, both KPATH and Insignia have the ability to
design fingerprints that are common to multiple target
genomes. To our knowledge, KPATH and Insignia are the
only tools other than TOFI [4] that have the provision for
in silico sequence-based testing for specificity against mul-
tiple nontarget genomes.
Neither KPATH nor Insignia is applicable for designing
microarray fingerprints, as the design and specificity
requirements of microarray fingerprints are quite different
from those of PCR signatures. For example, the most com-
monly used PCR signatures consist of a probe and two
primers, which, due to their short length [18–25 base
pairs (bp)] and constraints on the inter-primer distance,
can tolerate inexact matches with nontarget sequences
without much degradation in specificity. Conversely, in
addition to being characterized by only one DNA segment
with no spacing constraints, microarray probes are gener-
ally longer and more susceptible to cross-hybridization
even in the absence of an exact match [20]. This requires
more extensive searches, for both exact and inexact
matches, against nontarget sequences to identify highly
specific fingerprints for microarrays.
Implementation
The TOFI pipeline consists of the three main stages illus-
trated in Figure 1. The stages are designed so that large
portions of the target genome are eliminated in the less-
expensive two initial stages, and the computationally
more expensive searches for specific fingerprints are per-
formed over smaller regions of the target genome in the
final stage.
The first stage uses the suffix-tree-based MUMmer [21] pro-
gram to perform pairwise comparisons of the target
genome with each nontarget genome and eliminates
regions in the target genome that have exact matches with
one of the nontarget genomes. The surviving regions of
the target genome, called candidate sequences, are then
passed on to the second stage of the pipeline. Given a pair
of sequences, MUMmer finds all maximal matches that
are at least as long as a threshold (termed minmatch)
between the two sequences. TOFI uses MUMmer to find
these maximal matches, and eliminates regions in the tar-
get genome that are covered by these maximal matches.
The threshold to use for minmatch is calculated based on
the specificity parameters supplied by the user. This
ensures that every segment of the target genome that is at
least as long as the minimum probe length and satisfies
the specificity parameters is part of a candidate sequence.
Stage 2 identifies oligonucleotides of desired length from
the candidate sequences that satisfy experimental condi-
tions, such as melting temperature (Tm) and GC content.
TOFI uses the Oligonucleotide Modeling Platform (OMP)
software [22] to identify these oligonucleotides, also
referred to here as probes. OMP uses the nearest neighbor
hybridization model [23] to calculate Tm and to estimate
if a probe forms any secondary structures that may prevent
it from hybridizing to the target genome.
In the third and final stage of the pipeline, TOFI performs
a BLAST [24] search against a local copy of the NCBI nt
database for each probe. The program uses mpiBLAST
[25] to run BLAST in parallel on multiple processors.
Probes with alignments to nontarget genomes that exceed
the specificity thresholds are eliminated, and the surviving
probes become the in silico DNA fingerprints for the target
genome. These probes are then subjected to experimental
validation to test their sensitivity and specificity.
TOFI-beta incorporates major modifications in the first
and third stages of the pipeline to increase computational
The three stages of the TOFI-beta pipeline Figure 1
The three stages of the TOFI-beta pipeline. On aver-
age, about 90% of the total computation time is spent in 
Stage 3.
Filter the probes based on approximate and exact 
matches with all sequenced nontargets 
Design DNA microarray probes based on 
experimental requirements  
Discard common DNA based on exact matches 
one or more near-
neighbor genomes  target genome 
candidate sequences 
Stage 1 
oligonucleotide probes 
in silico DNA fingerprints
Stage 2 
Stage 3 BMC Bioinformatics 2008, 9:185 http://www.biomedcentral.com/1471-2105/9/185
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speed and enhance the specificity assessment of the fin-
gerprints. In the following, we compare TOFI-beta and
TOFI-alpha and describe these improvements.
Improvements in Stage 1
In Stage 1, the major improvement in TOFI-beta over
TOFI-alpha is the comparison of the target against multiple
nontarget genomes for finding exact matches. TOFI-alpha
only allows for comparison against a single nontarget
sequence. Comparison against a single genome is effective
in eliminating a large portion of the target genome when
a closely-related, nontarget near-neighbor genome
sequence is available. However, when such a nontarget
sequence is not available, too many candidate sequences
are passed on to the later stages of the pipeline, which are
computationally more expensive. Even when a closely-
related, nontarget near-neighbor is available, compari-
sons against additional nontarget genomes is advanta-
geous. As Stage 1 is relatively inexpensive, the additional
time spent in this stage is offset by the much larger reduc-
tion in computation time in the later steps, yielding a very
favorable trade-off in overall runtime. Potentially, the tar-
get genome could be compared with all nontarget
sequences in the entire nt database.
As described by Tembe et al. [4], sequence comparisons
for exact matches in Stage 1 are performed using the nuc-
mer  module in MUMmer. Some modifications were
required in TOFI-beta, however, to avoid some perform-
ance issues when using a large database of nontarget
sequences. Since the larger databases are too big for
MUMmer, they are split into smaller databases and the
target sequence is compared for exact matches against the
smaller databases. This procedure is parallelized in TOFI-
beta so that the target sequence is compared against a dif-
ferent set of nontarget sequences at each processor. The
results are then assembled and processed so that only
unique regions of the target genome are passed on to the
next stage.
Improvements in Stage 3
In Stage 3, each probe that is generated in Stage 2 is
screened for cross-hybridization against all available non-
target genome sequences in the nt database using BLAST
[24]. Stage 3 is, by far, the most computationally expen-
sive stage, which takes about 99% of the total runtime of
TOFI-alpha.
In TOFI-alpha, Stage 3 consists of a single step in which a
BLAST search is performed for each probe against the
complete nt database. In contrast, as illustrated in Figure
2, the third stage in TOFI-beta consists of multiple, hierar-
chical BLAST steps, with the computational cost of the
BLAST searches increasing with the number of steps. At
each step, the oligonucleotide probes having significant
alignments with nontarget sequences are removed, and
only the surviving probes are passed on to the next, more
expensive step. In the first step, we use the pairwise BLAST
program bl2seq to identify matches with a near-neighbor
genome, and the probes that meet the specificity require-
ments are passed on to the subsequent steps. In the
absence of a near-neighbor genome, this step is bypassed.
The subsequent steps consist of a series of BLAST searches
using blastn, where at each step the probes are queried
against increasingly larger nucleotide databases of more
distantly-related organisms to the target organism. For
example, when Yersinia pestis is the target organism, the
probes are first queried against databases consisting of
sequences of Proteobacteria, then all other bacteria, and
finally the nt database. Because the time taken to perform
a BLAST search increases with database size and a probe is
more likely to match sequences of closely-related organ-
isms, the strategy in TOFI-beta is to perform relatively less
expensive BLAST searches against small databases of
related organisms first, eliminating many nonspecific
probes before performing more comprehensive and costly
BLAST searches. The hierarchical sequence databases are
manually constructed. The probes that meet the specificity
criteria in all BLAST steps are provided as the in silico DNA
fingerprints for the target organism.
Improved specificity criteria
Probes designed for pathogen identification have to be
unique to the target organism, and should not cross-
hybridize with any nontarget organism. High sequence
similarity between a probe and a nontarget sequence,
apparent from the presence of good pairwise sequence
alignments, is generally indicative of cross-hybridization
between the two. There are multiple criteria for determin-
ing the specificity of a probe: overall sequence similarity,
contiguous matches, and predicted free energy have all
been shown to be important measures of the potential for
cross-hybridization [26]. In addition to these criteria, we
propose the use of near-contiguous matches (i.e., long
stretch of matches with very few mismatches, insertions or
deletions) to measure probe specificity.
Sequence similarity, i.e., the number of matches (or mis-
matches) in the alignment between two sequences, is one
criterion for estimating cross-hybridization. This criterion
measures only the matching bases. That is, it does not take
into consideration how the matches are distributed in the
alignment. TOFI-alpha uses the number of mismatches in
the alignment, denoted by T, as the sole criterion for
determining probe specificity. However, when the probe
length is variable, specifying the matching bases as a per-
centage of the probe length allows for a more consistent
measure of similarity, as a single threshold can be used forBMC Bioinformatics 2008, 9:185 http://www.biomedcentral.com/1471-2105/9/185
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various probe lengths. The percentage of matching bases
in the alignment between two sequences is commonly
referred to as the identity of the two sequences. In TOFI-
beta, we use sequence identity as one of several criteria for
estimating cross-hybridization.
In order to incorporate contiguous and near-contiguous
matches in determining probe specificity, we use a series
of thresholds M0, M1, M2, and M3, where Mi is the maxi-
mum length of a contiguous region in which the align-
ment between a probe and a nontarget sequence has (Mi -
i) matches and i  mismatches/insertions/deletions.
Accordingly, M0 is the length of the longest stretch of con-
tiguous matches between a probe and a nontarget
genome.
The use of multiple criteria for specificity is deemed to
yield a number of advantages. First, other factors, apart
from overall sequence identity, influence the hybridiza-
tion of a probe to a nontarget sequence. Kane et al. [27]
performed empirical analysis on 50 mer oligonucleotides
in order to measure, among other things, the effect of
overall sequence identity and contiguous stretches of sim-
ilarity on cross-hybridization. They concluded that a
probe is likely to cross-hybridize with a nontarget if over-
all sequence identity is > 75% or if there is a contiguous
match > 15 bp. Li et al. [26] also concluded that better spe-
cificity can be obtained by using multiple criteria, such as
sequence identity, length of contiguous matches and
hybridization energy.
Second, the use of multiple criteria for specificity gives
finer control; one can relax the threshold value for each
individual criterion and yet obtain more in silico finger-
prints with comparable specificity to fingerprints that can
be obtained using a single criterion. Conversely, using a
single criterion does not give much control over the spe-
cificity of the selected probes. Applying strict thresholds
for a single criterion might result in missing many specific
probes, whereas relaxing the thresholds may lead to too
many nonspecific probes [20].
Stage 3 of TOFI-beta Figure 2
Stage 3 of TOFI-beta. The initial BLAST step is optional. It is bypassed if a near-neighbor genome is not available. The data-
bases used in the intermediate BLAST steps must consist of organisms that are closely related to the target pathogen.
bl2seq against the near-neighbor genome 
BLAST against the entire nt database 
probes from Stage 2 
surviving probes 
surviving probes 
in silico fingerprints 
initial BLAST step  
final BLAST step  
Variable number of intermediate BLAST steps 
with increasingly larger nucleotide databases 
intermediate BLAST steps  BMC Bioinformatics 2008, 9:185 http://www.biomedcentral.com/1471-2105/9/185
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An additional advantage is that using multiple specificity
criteria, including contiguous matches, improves runtime.
The selection of specificity criteria affects the choice of the
length of minimum exact matches in Stage 1, and using
multiple criteria allows for the selection of a smaller
threshold for minimum exact matches. This selection
results in fewer candidate sequences passing Stage 1,
thereby improving the overall pipeline performance.
The thresholds M1, M2, and M3 help design robust finger-
prints that are not affected by small variations in nontar-
get sequences. Using M1,  M2, and M3  one can avoid
situations in which a small number of mutations/inser-
tions/deletions in a nontarget sequence might potentially
lead to long stretches of contiguous matches between the
probe and nontarget, causing the probe to cross-hybridize
with the nontarget. For instance, in the example shown in
Figure 3, the probe does not have a very long stretch of
contiguous matches with a nontarget, but rather a long
near-contiguous match. In this instance, the probe might
cross-hybridize with the nontarget because of the long
stretch of near-contiguous match. The threshold M1 is par-
ticularly useful in avoiding regions around common sin-
gle nucleotide polymorphisms between the target and
nontarget genomes.
Using free energy (ΔG) for probe selection
Li et al. [26] have suggested that free energy (ΔG) is an
important measure of probe specificity. However, com-
puting the ΔG between a probe and nontarget sequences
involves traversing through each nontarget genome and
computing ΔG for each alignment with the probe. Given
the large number of nontarget genomes and the relatively
high computational cost of each ΔG calculation, such an
approach is not practical for the current application. A
more feasible strategy would be to obtain the BLAST hits
for the probe and compute ΔG against each significant hit.
However, even this strategy would be impractical, owing
to the large number of fingerprints reported at the end of
Stage 2. A feasible strategy is to perform the calculations
only at the very final stage, after the probes have been
screened using other specificity criteria. Hence, ΔG estima-
tion (computed with OMP) is provided as an optional
post-processing step in TOFI-beta.
Results
The TOFI pipeline can design oligonucleotide probes of
any length. The results that we present here are for the
design of variable-length probes with length varying from
35 to 40 bp. The choice of probe length was solely based
on the requirements of the downstream field-deployable
microarray platform for which these probes are designed,
and hence we do not attempt to find optimal probe
lengths for pathogen identification. In general, shorter
probes result in better specificity, and longer probes result
in better sensitivity [28,29].
Performance improvements
To compare runtimes of TOFI-beta and TOFI-alpha under
similar conditions, we conducted tests with T as the only
specificity criterion in both, although TOFI-beta can make
use of multiple specificity criteria as described above.
Table 1 shows comparative runtimes for four different
genomes with T = 9, which is a practical threshold for
probes with lengths between 35 and 40 bp. It can be seen
that TOFI-beta is at least twice as fast as and almost as
much as five times faster than TOFI-alpha in all test cases.
The results in Table 1 are representative of runs with other
bacterial pathogens.
The performance gains obtained in TOFI-beta are partly
due to using more near-neighbor genomes in Stage 1, and
partly due to using multiple hierarchical steps in the
BLAST stage. Table 2 shows a stage-by-stage comparison
for F. tularensis using 74 processors. In this case, TOFI-beta
is nearly five times faster than TOFI-alpha, where about
half of the speedup is the result of using multiple nontar-
get genomes in Stage 1. The changes in Stage 1 reduce the
number of probes reaching Stage 3 by 44%, from 33299
in TOFI-alpha to 18668 in TOFI-beta, where the addi-
An alignment with a long near-contiguous match Figure 3
An alignment with a long near-contiguous match. In the alignment, the longest contiguous match is only 17 bp, but the 
longest near-contiguous match with one mismatch is 27 bp.
Probe   GATAGACTGTTGAGTCAATCGCATGGTCGTGGACG
|||||||||||||||||x|||||||||x|||||||
Nontarget GATAGACTGTTGAGTCAGTCGCATGGTAGTGGACGBMC Bioinformatics 2008, 9:185 http://www.biomedcentral.com/1471-2105/9/185
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tional time for carrying out these steps (31 minutes) is off-
set by the much larger reduction in computation time in
Stage 3 (nearly 11 hours, not shown in Table 2). The rest
of the gains in performance are the result of hierarchical
filtering in the BLAST stage. The initial and intermediate
inexpensive BLAST steps eliminated 15288 probes out of
the 18668 probes in less than two hours, which would
have taken more than 10 hours if a single BLAST step were
to be used as in TOFI-alpha.
The optimum number of BLAST steps depends on many
factors, including the size of the target genome, the avail-
ability of genomic sequences from closely-related, nontar-
get genomes, and the number of processors available.
Based on empirical evidence obtained by running the
pipeline for various bacterial genomes, we observe that
the use of one intermediate BLAST step is optimal in
reducing the overall runtime. Additional BLAST steps do
not reduce the runtime significantly when a large number
of processors (> 30) are available. However, when a lim-
ited number of processors are available, using additional
BLAST steps might be useful in reducing the overall runt-
ime.
Effect of multiple specificity criteria
Table 3 compares the numbers of in silico fingerprints
obtained by using T  versus using sequence identity
together with four measures for match contiguity (M0, M1,
M2, and M3). In all four cases, the number of fingerprints
obtained is higher using multiple parameters, with the
numbers being significantly higher in three out of the four
test cases. Empirical analysis on various organisms reveals
that a threshold of eight (or 10) for T results in too few (or
too many) in silico fingerprints to test in a single microar-
ray experiment. A threshold of T = 9 yields a more reason-
able number of fingerprints in most cases. The thresholds
for the match contiguity parameters were selected by start-
ing with baseline values recommended in the literature
[20,27,30], and making necessary adjustments to obtain a
reasonably large number of fingerprints. Thresholds for
identity and contiguous matches (M0) are based on the
values suggested by Kane et al. [27] for 50 mer oligonucle-
otides. We find that the thresholds suggested, identity =
75% and M0 = 15, are too strict, with few probes passing
these thresholds when matches with all nontarget
genomes are taken into consideration. Therefore, we
relaxed the thresholds to identity = 80% and M0 = 18. The
thresholds of 22, 26, and 30 for near-contiguous matches
M1, M2, and M3, respectively, were selected based on the
threshold used for M0. We expect that relaxing the thresh-
olds for identity and contiguous matches will not decrease
the specificity of the fingerprints reported, because the
thresholds for near-contiguous matches (M1, M2, and M3)
help eliminate some nonspecific probes that satisfy the
thresholds for identity and contiguous matches.
Case studies: Francisella tularensis and Yersinia pestis
In the following, we present a detailed comparative anal-
ysis of the number and specificity of fingerprints obtained
by using individual versus multiple specificity criteria.
Table 2: Comparison of TOFI-alpha and TOFI-beta for the F. tularensis genome on 74 processors
TOFI-alpha TOFI-beta
Stage Step Time Output Time Output
1 MUMmer with near-neighbor 1 m 1730 candidates, 1889863 bp 1 m 1730 candidates, 1889863 bp
1 MUMmer with Proteobacteria - - 8 m 1882 candidates, 1768235 bp
1M U M m e r  w i t h  nt database - - 23 m 2140 candidates 1192259 bp
2O M P 2 m 33299 probes 2 m 18668 probes
3 bl2seq with near-neighbor - - 5 m 6979 probes
3 BLAST with Proteobacteria - - 1 hr 37 m 3380 probes
3B L A S T  w i t h  nt database 22 hrs 1469 fingerprints 2 hrs 13 m 1469 fingerprints
Total execution time 22 hrs 4 hrs 29 m
For both TOFI-alpha and TOFI-beta, T = 9 is used as the sole specificity criterion.
Table 1: Performance comparison of TOFI-alpha and TOFI-beta
Genome (length in base pairs) Near-neighbor (length in base pairs) TOFI-alpha runtime (hrs) TOFI-beta runtime (hrs) Improvement
Yersinia pestis (4653728) Yersinia pseudotuberculosis (4744671) 11 4 275%
Francisella tularensis (1892819) Francisella philomiragia (2049711) 22 5 440%
Burkholderia mallei (5835527) Burkholderia thailandensis (6723972) 21 7 300%
Brucella melitensis (3294931) Agrobacterium tumefaciens (2074782) 55 21 261%
The runtimes are rounded off to the nearest hour. All runs were carried out on 74 processors.BMC Bioinformatics 2008, 9:185 http://www.biomedcentral.com/1471-2105/9/185
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Our aim is to consider all potential probes that satisfy the
experimental constraints and evaluate the specificity crite-
ria based on estimated ΔG of these probes with nontarget
genomes. Accordingly, we evaluated all the probes result-
ing from Stage 2, where in Stage 1 we compared the target
with a single near-neighbor genome using an exact match
threshold of 32 bp. The results presented here are for F.
tularensis SCHU S4 (NCBI accession no. NC_006570) and
Y. pestis CO92 (NCBI accession no. NC_003143). A contig
from F. philomiragia ATCC 25017 [31] was used as the
near-neighbor for F. tularensis, and Y. pseudotuberculosis IP
32953 (NCBI accession no. NC_006155) was used as the
near-neighbor for Y. pestis.
Probe design on the candidate sequences, taking into con-
sideration the experimental constraints (probe length
between 35 and 40 bp, Tm between 70 and 100°C and GC
content between 45 and 50%), yielded a total of 33299
probes for F. tularensis and 19810 probes for Y. pestis.
BLAST searches were performed on these probes against
the entire nt  database downloaded from NCBI in July
2007. BLAST hits with the corresponding targets and syn-
thetic constructs were ignored. The remaining BLAST hits
were extended on either side by 50 bp, and ΔG with the
corresponding probe was estimated using the simulation
feature of the OMP software. For each probe, the largest
negative ΔG value among all BLAST hits was taken as a
conservative measure of cross-hybridization between the
probe and a nontarget sequence.
The probes are categorized into good, bad, or gray based on
their  ΔG values, as actual experimental hybridization
results are not available for these probes. Good probes are
expected to have little or no cross-hybridization with non-
target genomes, bad probes are expected to have signifi-
cant cross-hybridization, and the behavior of gray probes
is too uncertain to categorize either way. Estimated ΔG
should not, however, be construed as a substitute for
experimental hybridization tests. We heuristically selected
well-spaced ΔG thresholds for good and bad probes in
order to assess the relative performance of the different
specificity criteria. Probes with ΔG greater than or equal to
-16 kcal/mol are categorized as good probes. This thresh-
old was selected because it corresponds to about 50% of
the mean ΔG between a probe and its complement, which
is the approximate ratio recommended for 50 mers [20].
Probes with ΔG less than -20 kcal/mol (less than 60% of
the mean ΔG between a probe and its complement) are
considered as bad probes. The probes with ΔG between -
20 and -16 kcal/mol are labeled as gray probes. Further
increase in separation between good and bad probes is
not convenient because it reduces the sample size for
comparative assessment.
Figure 4 shows the variation of the number of good and
bad probes for F. tularensis as a function of thresholds for
six different individual specificity criteria. It can be seen
that, for each individual criterion, the percentage of good
probes increases sharply within a narrow range of thresh-
olds. In most cases, the percentage of bad probes closely
follows the percentage of good probes, with the effect that
none of the thresholds for the individual criteria are help-
ful in admitting a large percentage of good probes while
simultaneously rejecting a large percentage of bad probes.
We obtained similar results for Y. pestis.
Figure 5 shows the numbers of good and bad probes
obtained by using different thresholds for each individual
specificity criterion and different combinations of values
for the multiple specificity criteria, for both F. tularensis
and Y. pestis. One interesting observation is that the total
number of good probes obtained for Y. pestis is much
smaller than that for F. tularensis. This is not surprising.
Given the larger availability of sequence information for
organisms related to Y. pestis, we expect a larger propor-
tion of Y. pestis probes to cross-hybridize with nontarget
sequences, decreasing the number and proportion of
good probes. The most significant observation is that, in
both cases, there are very few scattered points for each
individual criterion (T, M0, identity) and there are signifi-
cant discrete changes in the numbers of probes for each of
these few entries. This suggests that the use of individual
specificity criteria provides limited flexibility to control
for the potential number of probes. Conversely, the use of
multiple specificity criteria provides an almost continu-
ous spectrum of options. Since, in the probe selection
process, we wish to maximize the number of good probes
and simultaneously minimize the number of bad probes,
we use the Pareto optimality principle [32] to select com-
binations of specificity parameters that optimize this dual
objective. The Pareto optimal front contains solutions to
a multiobjective optimization problem that are best in
Table 3: The number of fingerprints obtained using different specificity criteria for four different target organisms
Genome T = 9 identity = 80%, M0-M1-M2-M3 = 18-22-26-30
Yersinia pestis 614 836
Francisella tularensis 1469 2028
Burkholderia mallei 572 1146
Brucella melitensis 1352 7659BMC Bioinformatics 2008, 9:185 http://www.biomedcentral.com/1471-2105/9/185
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Percentages of good and bad probes for different individual specificity criteria for F. tularensis Figure 4
Percentages of good and bad probes for different individual specificity criteria for F. tularensis. Identity and T 
(number of mismatches, presented in Figure 4a as the difference between the average probe length Lavg and T) are different 
ways of measuring sequence similarity. M0 is the maximum length of contiguous matches, and M1, M2, and M3 are measures of 
near-contiguous matches. It can be seen that none of the thresholds for the individual criteria are effective in clearly discrimi-
nating between good and bad probes.
 
good probes 
 
bad probes BMC Bioinformatics 2008, 9:185 http://www.biomedcentral.com/1471-2105/9/185
Page 10 of 13
(page number not for citation purposes)
Good versus bad probes for different combinations of individual and multiple specificity criteria Figure 5
Good versus bad probes for different combinations of individual and multiple specificity criteria. Each light blue 
dot represents a combination of thresholds for the multiple criteria (identity, M0, M1, M2, and M3). The Pareto optimal front, 
defined as the scattered points with the smallest number of bad probes for a specified number of good probes, is shown in 
dark blue. The scattered points corresponding to strict thresholds for each individual criterion are close to the Pareto optimal 
front, but quickly move away from it as the thresholds are relaxed.BMC Bioinformatics 2008, 9:185 http://www.biomedcentral.com/1471-2105/9/185
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satisfying all of the objectives simultaneously. That means
that there can be other solutions that are better in satisfy-
ing one or several objectives, but they must be worse than
the Pareto optimal solution in satisfying the remaining
objectives. In our case, the Pareto optimal front identifies
the scattered points with the smallest number of bad
probes for a given number of good probes. The scattered
points for the individual criteria consistently drift away
from the Pareto optimal front as the number of good
probes increases. This trend further suggests that multiple
specificity criteria should be used if one is interested in
obtaining a larger number of good in silico probes, while
simultaneously admitting fewer bad probes.
Table 4 shows the numbers of good, bad and total
(including gray) probes that pass different combinations
of specificity criteria. The results clearly indicate the obser-
vation made above that the use of individual specificity
criteria (T, identity, M0, etc.) does not provide fine control
over the number of in silico fingerprints. Some selections
provide either too few or too many probes. For example,
a selection of T = 10 yields 310 probes for F. tularensis,
while a selection of T  = 8 yields 4810 probes. Similar
behavior is also observed for other individual criteria. For
instance, while M0 = 16 yields 1580 probes, M0 = 17 yields
4254. Such large changes in the number of probes with
small changes in specificity thresholds are not desirable in
experimental testing. The customized microarray plat-
form (Agilent Technologies [33]) that will be used for
experimental testing consists of a slide with eight arrays.
Though each array contains 15000 features, the inclusion
of controls and at least five replicates per probe limits the
actual number of probes on each array to around 2000.
Using multiple criteria (first three rows in Table 4), how-
ever, we can achieve the desired number of probes by
adjusting the thresholds, as small changes in individual
thresholds do not lead to large differences in the number
of in silico fingerprints.
Discussion
Effect of database size on specificity thresholds
The size of the target genome and the size of the database
of nontarget sequences affect the selection of thresholds
for contiguous and near-contiguous matches. For the size
of target genomes and nontarget databases used in this
paper, M0 = 18 appears to be an appropriate threshold,
resulting in sufficient number of fingerprints for all the
genomes in Table 3. However, as more and more nontar-
get sequences become available, it might not be possible
to find unique 18 mers. Reed et al. [28] present a model to
estimate the quality of a probe based on the size of the
database of nontarget sequences. According to this model,
the probability of finding a unique 18 mer is close to zero
when the size of database is 100 Gb. As the size of
sequence databases is quickly approaching this number, it
might be necessary to use higher thresholds for M0 and
other specificity parameters.
Table 4: The numbers of good, bad and total probes (including gray) obtained for different specificity thresholds
Thresholds for specificity criteria F. tularensis Y. pestis
Good Bad Total Good Bad Total
Identity = 80%, M0-M3 = 18–22–26–30 748 46 2028 215 44 836
Identity = 80%, M0-M3 = 19–22–25–28 820 63 2451 260 67 1042
Identity = 82.5%, M0-M3 = 19–22–25–28 1142 113 3532 359 111 1587
Identity = 75% 195 22 473 94 42 305
Identity = 77.5% 788 88 2019 232 112 833
Identity = 80% 2143 379 7199 583 368 2608
T = 8 1656 265 4810 442 291 1895
T = 9 621 58 1496 193 93 614
T = 10 156 12 310 60 24 153
M0 = 16 483 193 1580 96 187 628
M0 = 17 1127 545 4254 208 534 1521
M0 = 18 2632 1230 10665 491 1581 4040
M1 = 20 418 119 1654 118 87 610
M1 = 21 1857 523 7174 431 506 2581
M1 = 22 3579 1226 14973 3758 1106 4952
M2 = 23 486 90 1722 157 91 802
M2 = 24 1646 383 6628 432 366 2567
M2 = 25 3293 962 13967 771 751 4714
M3 = 25 86 11 393 36 17 219
M3 = 26 691 151 2866 223 160 1314
M3 = 27 2026 533 8504 534 480 3305BMC Bioinformatics 2008, 9:185 http://www.biomedcentral.com/1471-2105/9/185
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Limitations of using BLAST
Even though BLAST is among the best methods for
sequence comparisons against large databases like the nt
database, BLAST has its limitations. BLAST is a heuristic
approach that first finds short, exact, "anchor" matches
and extends the alignments around these exact matches.
The size of these exact matches, termed word size, is given
by the input parameter W. In the blastn program, used for
BLAST searches against large sequence databases, the
default value for W is 11 and the smallest possible value
W can take is 7. Because every match reported by BLAST
must include an exact match of length W, it imposes a
lower bound on the values of the specificity thresholds
M0, M1, M2, and M3. For any given W, the smallest near-
contiguous match with i mismatches that can be guaran-
teed to be reported by BLAST is given by W(i+1), there-
fore, the minimum allowable value for any Mi is W(i+1)-
1. Accordingly, the lowest thresholds of M1, M2, and M3
for W = 7 are 13, 20, and 27, respectively. Using lower
thresholds for Mi could result in some near contiguous
matches of length Mi not being reported by BLAST.
Errors in sequence databases
TOFI currently uses the description provided in the header
line of a FASTA sequence to determine if the sequence is a
target or a nontarget sequence. Typographical errors or
missing information in the NCBI sequence data can some-
times cause TOFI to treat a sequence from a target organ-
ism as a nontarget sequence, which can potentially lead to
removal of good fingerprints.
The fingerprints designed by TOFI can only be as accurate
as the sequence databases used for comparisons with non-
target sequences. However, identifying the errors and
removing low-quality data from sequence databases is
beyond the scope of the TOFI framework. The only com-
plete solution for handling errors in sequence data is to
use manually curated sequence databases that contain
only high-quality sequences with accurate sequence
descriptions.
Extension to multiple genomes
The performance improvements in TOFI-beta pave the
way for extending the pipeline to design probes common
to a group of target genomes, e.g., multiple strains of a
species and multiple species of a genus. The identification
of common fingerprints is a more computationally inten-
sive problem, as it requires the simultaneous analyses of
multiple target genomes. In the future, we will extend the
software pipeline to design sets of fingerprints common to
multiple targets and sets unique to each target, taking
maximum advantage of the shared sequences among the
multiple genomes in order to reduce the overall computa-
tion time.
Conclusion
The enhanced pipeline incorporates major algorithmic
improvements, resulting in performance that is nearly up
to five-times faster than the previous version of the pipe-
line. The use of multiple specificity criteria provides finer
control over the number of resulting fingerprints. This is
helpful in obtaining a larger number of in silico finger-
prints than those obtained using individual criteria, and
may be essential for the following three reasons: (1) as
more and more genomic sequences become available,
there will be significant fingerprint erosion; matches with
the newly available sequences will eliminate some finger-
prints, (2) certain near-neighbor organisms may have very
similar sequences, so, in these cases, obtaining a larger
number of potential in silico fingerprints for experimental
testing would be desirable, and (3) due to the noisy nature
of microarray experiments, redundancy is essential for
confidence in the results. Therefore, it is desirable to start
with a sufficiently large number of in silico fingerprints,
and identify specific fingerprints based on experimental
results with the target and a panel of nontarget sequences.
Availability and requirements
￿ Project name: TOFI
￿ Project home page: http://www.bhsai.org/downloads/
tofi_beta.tar.gz
￿ Operating systems: Linux
￿ Programming Language: Perl
￿ Other Requirements: mpiBLAST 1.4.0 or higher, MUM-
mer 3.19 or higher, and OMP developer edition
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